Shaily Engineering Plastics Limited (SEPL) reported impressive Q1 FY26 results with revenue up 38% to ₹246.70 crores, EBITDA up 95% to ₹70.40 crores, and PAT up 136% to ₹41.10 crores. The healthcare segment, particularly GLP-1 pen devices, was a key growth driver, with segment revenue soaring 181% to ₹77.20 crores. SEPL has commenced commercial manufacturing of GLP-1 pens for semaglutide and is expanding capacity with planned capex of ₹125.00 crores in FY26. The company expects continued growth in the healthcare segment and is in discussions with customers for future volume commitments.
11Aug 25
Shaily Engineering Plastics Reports Q1 Results, Re-appoints Whole-time Director
Shaily Engineering Plastics Limited (SEPL) reported robust Q1 financial results. Standalone revenue from operations reached ₹20,328.41 lakhs with a net profit of ₹2,376.10 lakhs. Consolidated revenue stood at ₹24,669.27 lakhs with a net profit of ₹4,112.27 lakhs. The company announced the re-appointment of Mrs. Tilottama Sanghvi as Whole-time Director, set a dividend record date, and approved a revised Code of Conduct for Prevention of Insider Trading. SEPL also invested AED 100,000 in its Dubai subsidiary, Shaily Innovations FZCO, to boost international presence.
Shaily Engineering Plastics Ltd. (SEPL) has seen its shares rise over 300% since its IPO two years ago, establishing itself as a multibagger stock. The company reported robust Q4 results with revenue growth of 27.7% and net profit increase of 47.9% year-on-year. Renowned investor Ashish Kacholia holds a 3.22% stake in SEPL. The company specializes in manufacturing high-precision injection molded plastic components for various industries including home furnishings, automotive, FMCG, and healthcare sectors.
13May 25
Shaily Engineering Plastics Reports Robust Q4 Results and Announces Dividend
Shaily Engineering Plastics Ltd. has announced impressive Q4 FY2023 results, with revenue up 29.41% to ₹2,200.00 crore, EBITDA increasing 57.06% to ₹545.00 crore, and net profit growing 48.19% to ₹286.00 crore year-over-year. The company's EBITDA margin expanded by 468 basis points to 25.02%. Additionally, a dividend of ₹2 per equity share has been recommended.